SCHEMBL7963436

SCHEMBL7963436

O=C(CCc1cnc2n1CCCCC2)N1CCC(c2ccc(Cl)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.51
MCHR1 Q99705 6/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GRM5 P41594 1/20 0.43
HPGD P15428 4/20 0.40
RAB9A P51151 4/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HTR2C P28335 1/20 0.40
ME2 P23368 1/20 0.39
ME1 P48163 1/20 0.39
ME3 Q16798 1/20 0.39
NPC1 O15118 2/20 0.38
GAA P10253 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7960226 0.81 DRD2 (0.47) MCHR1SMN1; SMN2RAB9AKMT2AMEN1
SCHEMBL7963783 0.79 DRD2 (0.48) MCHR1SMN1; SMN2RAB9AKMT2AMEN1
SCHEMBL7960846 0.73 LMNA (0.43) SMN1; SMN2HPGDKMT2AALDH1A1MEN1
SCHEMBL8092580 0.71 GRM5 (0.53) MCHR1GRM5HPGDKMT2AALDH1A1
SCHEMBL5799909 0.71 MCHR1 (0.46) MCHR1GRM5
SCHEMBL5443358 0.71 F10 (0.65) F10SMN1; SMN2HPGDRAB9AKMT2A
SCHEMBL5443353 0.71 F10 (0.65) F10SMN1; SMN2HPGDRAB9AKMT2A
SCHEMBL10291524 0.70 NAMPT (0.59) MCHR1GRM5HPGDKMT2AALDH1A1
Hydrochloric Acid SCHEMBL947439 0.69 F10 (0.97) F10
SCHEMBL14434754 0.68 GRM5 (0.52) MCHR1GRM5RAB9AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed